Mr. Speaker, I hope again that the Prime Minister will take the opportunity to indicate where he stands on this issue.
The Prime Minister knows that the WTO has ruled against Canada on pharmaceuticals. That ruling will mean another $200 million drained from Canada's health care system to the multinational pharmaceutical manufacturers.
Is the government prepared to appeal that ruling, and what steps is Canada taking to ensure that the benefit of modern pharmaceuticals and of genetic research will be available to all human kind and not appropriated primarily for the commercial—